BioDD @BioDD5

Life-saving drugs over Fartcoin. Every time. Joined July 2012

Tweets

429
Followers

290
Following

1K
Likes

12K

El sordo @med__twi

3 weeks ago

Xevinapant with worse (!) EFS and PFS vs. placebo in phase 3 trial readout. Inhibitors of apoptosis protein inhibitors obviously not working as intended. ascopubs.org/doi/10.1200/JC… Also confirms how hard it is to develop new chemo/RT combinations. $MRK.DE #MerckKGaA

1 1 1 243 0

Download Image

BioDD @BioDD5

4 weeks ago

$PRTA Coramitug related cc:@given2tweet @AnotherBio

Ahmad Masri @MasriAhmadMD

4 weeks ago

$PRTA Coramitug related cc:@given2tweet @AnotherBio

2 4 22 4K 11

Download Image

0 0 0 456 0

Robert Coffin @robertcoffin3

2 months ago

Very much worth a listen for those who might have the time and are interested in the ongoing RP1 and $REPL story youtu.be/3myF9432BM8?fe…

0 2 20 4K 10

Jing Liang 🇺🇦 @AppleHelix

2 months ago

Robert Coffin @robertcoffin3

2 months ago

https://t.co/Rxw0216jjJ

0 0 8 4K 7

0 1 6 2K 2

Download Image

Sri Kosuri @srikosuri

2 months ago

Lilly: The culmination of decades of research, failed attempts, and countless billions of dollars gave us a cure for some of the most prominent and pernicious diseases. Sales: ~$15 billion Response: Drugs/Pharma are evil, kill the CEO, you are a bad person for using drugs.…

24 87 725 96K 90

STL Biotech @STL_Biotech

4 months ago

Best cardiology r/r at current price: $NAMS @ 2b large pop but another LDL lowering agent plus binary risk. $TRML @ 380m binary risk and will need funding/partner. $CYTK @ 3.7b path is clear, no/less binary risk but Robert Blum. $BBIO @ 7.7b EV commercial, competitive

1 2 18 9K 9

Maccabi Lev-Ari 🦁 @Maccabi226km

a year ago

Just wow The British telegraph smashes it H/T Raylan Givens

122 1K 7K 169K 450

Download Image

Jan Barta @absurdtrader

2 years ago

We live in a time increasingly resembling the second half of the 1930s. I couldn't live with myself with the knowledge I didn't do more to stop another Hitler. In light of the Republican wavering and in memory of Navalny I will give $100 towards FPV drones for Ukr for every RT.

1K 26K 20K 3.2M 693

Evan @StockMKTNewz

2 years ago

ASML is showing off its latest chipmaking machine, a $380 million behemoth that weighs as much as two Airbus A320s and that $ASML claims will be “essential” for chipmakers who want to participate in the AI boom Installation of the first 331K pound system required 250 crates, 250…

73 407 2K 561K 452

Download Image

Sound Dobad @SoundDobad

2 years ago

“The Indian rupee is backed by nothing.” Me: are you sure?

238 707 8K 1.1M 1K

Download Video

CKG @ckg1856

5 years ago

$PCVX super early but a lot of smart money likes it so has me intrigued. VAX-24 greater coverage than next gen $PFE and $MRK products and makes Pneumovax 23 obsolete. Clears way for VAX-XP to come in and take full share. Even with valuation risk/reward much better than other IPOs

1 2 1 0 0

CKG @ckg1856

5 years ago

As a former avid reader of @ohadhammer blog I can’t imagine what he would say about current valuations and this crazy hype cycle. It used to be that $500mm market cap IPO’s with little/no data were stretched valuations. Now $1-2 billion or higher is the norm.

1 1 2 0 0

CKG @ckg1856

5 years ago

Update from $SNDX on menin inhibitor shortly. Looking for NPM1m responses and what % Gr3+ QTc. Readthrough to $KURA. $KURA recent regulatory update on KO-539 RP2D and call was odd. Don’t recall amendment like this during phase I for targeted therapy in past?

0 1 0 0 0

Jacob Plieth @JacobPlieth

5 years ago

If you're doing last-minute preparation for #ASH20 and missed my preview with @bradloncar yesterday here's the recording bit.ly/37AO1Sj

3 5 38 0 7

BioDD @BioDD5

5 years ago

I really like $GNCA here at $2. I don't have much faith in GEN-009 and vaccine approach for neoantigens in general (despite recent Vaccibody/Roche) but GEN-011, a cell program with TIL-like approach looks VERY interesting. IF they can show a response, baby $IOVA in the making.

0 0 4 0 1

BioDD @BioDD5

5 years ago

Hi @juliaskripkaser, please do you have estimates of $ACET cash position? As of June 30, 2020, RestorBio had $70.9 million in cash + Adicet Bio had $123 million pro forma cash + $10 million milestone received from Regeneron in August = ~200 million in cash. Is that correct? Thx